WhiteOak Capital Pharma and Healthcare Fund
WhiteOak's pharma fund has tilted decisively toward specialty and generic players while trimming exposure to larger-cap stalwarts like Dr. Reddy's and Alkem, signaling conviction in mid-tier growth opportunities. The sharp rise in Clearing Corporation holdings and eight new micro-cap pharma entries suggest the manager is hunting for undervalued niche plays amid sector consolidation. With nearly two-thirds invested in pharma and a concentrated top-10 of 48%, this portfolio trades diversification for targeted conviction in a healthcare recovery narrative.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Primary | ₹14.9960 | +8.63% | +17.04% | — | — |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| Onesource Specialty Pharma Limited | 1.32% |
| Senores Pharmaceuticals Limited | 0.85% |
| Anthem Biosciences Limited | 0.73% |
| Innova Captab Limited | 0.69% |
| Procter & Gamble Health Limited | 0.61% |
| Mankind Pharma Limited | 0.50% |
| Cohance Lifesciences Limited | 0.33% |
| 182 Days Tbill (MD 18/06/2026) | 0.03% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited INE044A01036 | 10.47% |
| 2 | JB Chemicals & Pharmaceuticals Limited INE572A01036 | 6.54% |
| 3 | Clearing Corporation of India Ltd | 4.57% |
| 4 | Laurus Labs Limited INE947Q01028 | 4.13% |
| 5 | Fortis Healthcare Limited INE061F01013 | 4.12% |
| 6 | Divi's Laboratories Limited INE361B01024 | 4.11% |
| 7 | Apollo Hospitals Enterprise Limited INE437A01024 | 4.02% |
| 8 | Glenmark Pharmaceuticals Limited INE935A01035 | 3.41% |
| 9 | Aurobindo Pharma Limited INE406A01037 | 3.33% |
| 10 | Max Healthcare Institute Limited INE027H01010 | 3.31% |
| 11 | Krishna Institute Of Medical Sciences Limited INE967H01025 | 3.13% |
| 12 | Sai Life Sciences Limited INE570L01029 | 3.02% |
| 13 | Lupin Limited INE326A01037 | 2.97% |
| 14 | Neuland Laboratories Limited INE794A01010 | 2.64% |
| 15 | Acutaas Chemicals Limited INE00FF01025 | 2.45% |
| 16 | Corona Remedies Limited INE02ZQ01018 | 2.43% |
| 17 | Thyrocare Technologies Limited INE594H01019 | 1.98% |
| 18 | Narayana Hrudayalaya Limited INE410P01011 | 1.93% |
| 19 | Emcure Pharmaceuticals Limited INE168P01015 | 1.83% |
| 20 | Rainbow Childrens Medicare Limited INE961O01016 | 1.79% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does WhiteOak Capital Pharma and Healthcare Fund hold?
WhiteOak Capital Pharma and Healthcare Fund holds 54 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 29.83% of NAV.
What is the largest holding in WhiteOak Capital Pharma and Healthcare Fund?
The largest position in WhiteOak Capital Pharma and Healthcare Fund is Sun Pharmaceutical Industries Limited, accounting for 10.47% of NAV in the Pharmaceuticals & Biotechnology sector.
Is WhiteOak Capital Pharma and Healthcare Fund a concentrated or diversified fund?
With a Gini coefficient of 0.474, WhiteOak Capital Pharma and Healthcare Fund is moderately concentrated. The HHI concentration index is 36,524 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 29.83% of the portfolio.
What is the market cap allocation of WhiteOak Capital Pharma and Healthcare Fund?
Based on SEBI's AMFI classification, WhiteOak Capital Pharma and Healthcare Fund's equity portfolio is split as: Large Cap: 21.91%, Mid Cap: 23.28%, Small Cap: 47.71%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does WhiteOak Capital Pharma and Healthcare Fund invest in most?
WhiteOak Capital Pharma and Healthcare Fund has the highest allocation to Pharmaceuticals & Biotechnology (62.31%), Healthcare Services (24.07%), Chemicals & Petrochemicals (3.98%). The fund is invested across 7 sectors in total.
How actively managed is WhiteOak Capital Pharma and Healthcare Fund compared to other Sectoral / Thematic funds?
WhiteOak Capital Pharma and Healthcare Fund has an Active Share of 88.01%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.
What changed in WhiteOak Capital Pharma and Healthcare Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, WhiteOak Capital Pharma and Healthcare Fund added 8 new stocks (including Onesource Specialty Pharma Limited) and exited 3 stocks (including Dr. Reddy's Laboratories Limited). Total holding count increased from 50 to 55 stocks.